Corpus Intelligence IC Memo — UNITY MEDICAL CENTER 2026-04-26 06:42 UTC
IC Memo — UNITY MEDICAL CENTER
Investment Committee Memorandum | TN | 49 beds | Grade D | EBITDA uplift $3.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UNITY MEDICAL CENTER

CCN 440007 | COFFEE, TN | 49 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

UNITY MEDICAL CENTER is a 49-bed community hospital in COFFEE, TN with $45.9M in net patient revenue and a -0.5% operating margin. The hospital serves a payer mix of 29.5% Medicare, 0.0% Medicaid, and 70.5% commercial.

Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.5% to 6.8% (+736bps).

Net Revenue HCRIS$45.9M
Current EBITDA COMPUTED$-239K
Operating Margin COMPUTED-0.5%
Occupancy HCRIS20.1%
Revenue / Bed COMPUTED$938K
Net-to-Gross HCRIS44.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
72
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -0.5% places it above the state median. Among 72 size-comparable peers (24-98 beds), the median margin is -0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNITY MEDICAL CENTER (Target)TN49$45.9M-0.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HORIZON MEDICAL CENTERTN96$141.3M15.3%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
FRANKLIN WOODS COMMUNITY HOSPITN80$110.3M18.7%
GREENEVILLE COMMUNITY HOSPITALTN81$104.5M-5.1%
CUMBERLAND MEDICAL CENTERTN72$84.3M-12.0%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$965K+210bp18mo
Cost to Collect4.5%2.5%$919K+200bp12mo
Denial Rate Reduction12.0%6.5%$910K+198bp12mo
A/R Days Reduction5200.0%3800.0%$559K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$965K
Cost to Collect
$919K
Denial Rate Reduction
$910K
A/R Days Reduction
$559K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.4M
Current EBITDA$-239K
+ RCM Uplift+$3.4M
Pro Forma EBITDA$3.1M
Current Margin-0.5%
Pro Forma Margin6.8%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-368K$32.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-368K$35.3M0.00x-100.0%
Bull Case9.0x11.0x$-331K$46.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-331K$50.5M0.00x-100.0%
Bear Case11.0x10.0x$-404K$15.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-404K$16.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 20.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 24-98 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-12.2% / P50=-0.6% / P75=9.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.